Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchglp-1mental healthprescribingobesity

GLP-1 Prescribing Rises Among Adults With Serious Mental Illness

Drug Topics reports increased uptake of GLP-1 medications in a population facing elevated metabolic risk.

PR
By Priya Raman · Science Reporter
Sep 16 14:09 ETSource: Drug Topics

The wire

  1. 01Study finds GLP-1 prescriptions increased among adults with serious mental illness.
  2. 02This group faces high obesity and diabetes burden, often from psychiatric medications.
  3. 03Outcomes, adherence and equity of access in this population remain unclear.

From the source

GLP-1 Prescribing Rose Among Adults With Serious Mental Illness

Read at news.google.com